C. Johnson

发表

In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin.

P. Furmanski, P. Braunschweiger, C. Johnson, 1989, Blood.

In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).

P. Furmanski, C. Johnson, C. A. Cook, 1990, Experimental hematology.

In vivo hematopoietic effects of tumor necrosis factor-alpha in normal and erythroleukemic mice: characterization and therapeutic applications.

P. Furmanski, C. Johnson, M. Chang, 1988, Blood.

Age and growth factors in porcine full‐thickness wound healing

F. Yao, E. Eriksson, S. Visovatti, 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

Survival after myocardial infarction in rats: captopril versus losartan.

J. Milavetz, S. Goldman, E. Morkin, 1996, Journal of the American College of Cardiology.

Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours.

D. Trump, J. Wakshlag, D. Russell, 2010, Veterinary and comparative oncology.

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer

K. Cease, A. Adjei, D. Trump, 2013, Cancer Chemotherapy and Pharmacology.

Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained.

G. Paine-Murrieta, C. Taylor, A. List, 1997, European journal of cancer.

Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.

R. Dhir, P. Hershberger, D. Trump, 2001, The Journal of urology.

Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.

R. Day, R. Dhir, D. Trump, 1997, Urology.

Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).

L. Mosekilde, C. Lees, J. Thomsen, 1999, Bone.

Macrophage control of normal and leukemic erythropoiesis: identification of the macrophage-derived erythroid suppressing activity as interleukin-1 and the mediator of its in vivo action as tumor necrosis factor.

P. Furmanski, C. Johnson, CS Johnson, 1990, Blood.

Interleukin-1: therapeutic potential for solid tumors.

C. Johnson, 1993, Cancer investigation.

Immunotherapeutic approaches to leukemia: the use of the Friend virus-induced erythroleukemia model system.

P. Furmanski, C. Johnson, M. Chang, 1990, Cancer research.

Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma.

Simon C Watkins, R. Auerbach, R. Modzelewski, 1994, Cancer research.

1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo.

P. Hershberger, D. Trump, Candace S. Johnson, 1999, Cancer research.

Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.

P. Hershberger, Wei-dong Yu, D. Trump, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1.

T. Mcguire, D. Trump, Candace S. Johnson, 2001, The Journal of biological chemistry.

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.

D. Smith, D. Trump, Candace S. Johnson, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Vitamin D: an antiproliferative agent with potential for therapy of squamous cell carcinoma.

M. C. McElwain, R. Modzelewski, C. Johnson, 1997, American journal of otolaryngology.

Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.

Wei-dong Yu, D. Trump, Candace S. Johnson, 1997, Cancer research.

Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha.

P. Furmanski, P. Braunschweiger, C. Johnson, 1991, Cancer research.

Unbiased determination of cytokine localization in bone: colocalization of interleukin-6 with osteoblasts in serial sections from monkey vertebrae.

R. Brommage, C. Jerome, C. Johnson, 2000, Bone.

In vitro studies on the mechanism of action of hepsulfam in chronic myelogenous leukemia patients.

P. Furmanski, N. Gibson, C. Johnson, 1990, Cancer research.

31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors.

P. Furmanski, J. Glickson, I. Constantinidis, 1989, Cancer research.

31P-Nuclear Magnetic Resonance Studies of the Effect of Recombinant Human Interleukin la on the Bioenergetics of RIF-1 Tumors1

P. Furmanski, J. Glickson, J. Wehrle, 2006 .

Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone.

D. Smith, Wei-dong Yu, D. Trump, 1998, Journal of the National Cancer Institute.

Interleukin-1α synergistic in vivo enhancement of cyclophosphamide- and carboplatin-mediated antitumor activity

Wei-dong Yu, D. Trump, C. Johnson, 1997, Cancer Immunology, Immunotherapy.

Release of soluble "blocking" and "suppressor" factors from normal lymphocytes treated with RNA from spleens of tumour-bearing mice.

J. Nawrocki, D. Vallera, M. Dodd, 1979, British Journal of Cancer.

Induction of permanent regression of Friend virus (FV) leukemia by adoptive transfer of T helper and not T cytotoxic cells.

P. Furmanski, C. Johnson, S. Thurlow, 1992, Leukemia research.

Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity.

P. Furmanski, C. Johnson, S. Pourbohloul, 1991, Experimental hematology.

A new immunocompetent murine model for oral cancer.

Candace S. Johnson, M. Schwartz, B. O'Malley, 1997, Archives of otolaryngology--head & neck surgery.

Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.

T. Grogan, T. Miller, Y. Frutiger, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Mechanism of macrophage reversal of Friend erythroleukemia: macrophage regulation of normal and leukemic erythropoiesis.

P. Furmanski, J. Marcelletti, C. Johnson, 1986, Cancer research.

Inhibition of CFU‐E Colony Formation by Resident Peritoneal Macrophages From Hybrids of BALB/c Mice

P. Furmanski, C. Johnson, Philip Furmanski, 1984, Journal of leukocyte biology.

Effect of treatment for 3 months with human parathyroid hormone 1-34 peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).

C. Lees, C. Jerome, C. Johnson, 1995, Bone.

P. Furmanski, P. Braunschweiger, C. Johnson, 1989, Blood.

The effect of adrenalectomy and dexamethasone on interleukin-1 alpha induced responses in RIF-1 tumours.

V. Ord, P. Furmanski, P. Braunschweiger, 1990, British Journal of Cancer.

Effects of inhibitors and activators of protein kinase C on late erythroid progenitor (CFU-e) colony formation in vitro.

P. Furmanski, D. M. Jenis, C. Johnson, 1989, International journal of cell cloning.

Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling.

P. Hershberger, T. Mcguire, Wei-dong Yu, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.

P. Furmanski, M. Egorin, K. Erkmen, 1994, Cancer research.

Vitamin D in the prevention and treatment of prostate cancer.

D. Trump, B. Konety, R. Getzenberg, 1999, Seminars in urologic oncology.

Immuno-Pharmacologic Purging of Breast Cancer from Bone Marrow

E. Shpall, R. Jones, W. Peters, 1991 .

Infection of Haematopoietic Stem Cells In Mice With Friend Virus Induced Erythroleukaemia

P. Furmanski, J. Marcelletti, C. Johnson, 1986, Cell and tissue kinetics.

Induction of leukemia regression in mice by immunotherapeutic transfer of T-lymphocytes.

P. Furmanski, C. Johnson, S. Thurlow, 1986, Cancer research.

Acute hemorrhagic necrosis of tumors induced by interleukin-1 alpha: effects independent of tumor necrosis factor.

P. Furmanski, P. Braunschweiger, C. Johnson, 1991, Journal of the National Cancer Institute.

Interleukin‐12 Gene Therapy Prevents Establishment of SCC VII Squamous Cell Carcinomas, Inhibits Tumor Growth, and Elicits Long‐term Antitumor Immunity in Syngeneic C3H Mice

L. Zitvogel, M. Lotze, J. Myers, 1998, The Laryngoscope.

Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells.

R. Mannix, J. Lazo, R. Modzelewski, 1996, Cancer research.

Inhibition of normal erythropoiesis in mice with Friend virus induced erythroleukemia.

P. Furmanski, J. Marcelletti, C. Longley, 1982, Experimental hematology.

Effect of C-reactive protein on granulocyte-macrophage progenitor cells.

P. Furmanski, J. Marcelletti, C. Johnson, 1982, The Journal of laboratory and clinical medicine.

Effects of amifostine and paclitaxel on growth of human ovarian carcinoma xenografts in the severe combined immune-deficient mouse: preliminary results.

C. Taylor, R. Capizzi, C. Johnson, 1996, Seminars in oncology.